Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2026 17:54 ET | Source: Robbins LLP

TCOM Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Fraud Class Action Against Trip.com Group Limited

Robbins LLP is Investigating Allegations that Trip.com Group Limited (TCOM) Understated the Risk of Regulatory Enforcement in Light of its Monopoly
March 11, 2026 20:19 ET | Source: Robbins LLP

Nektar Therapeutics Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the NKTR Securities Class Action

Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial
March 11, 2026 19:54 ET | Source: Robbins LLP

Soleno Therapeutics, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the SLNO Class Action

Robbins LLP is Investigating Allegations that Soleno Therapeutics(SLNO) Misled Investors Regarding the Viability and Efficacy of its Phase 3 Clinical Trial
March 11, 2026 19:13 ET | Source: Robbins LLP

Eos Energy Enterprises, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the EOSE Class Action

Robbins LLP is Investigating Allegations that Eos Energy Enterprises, Inc. (EOSE) Misled Investors Regarding its Business Prospects
March 11, 2026 19:10 ET | Source: Robbins LLP

Driven Brands Holdings Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the DRVN Class Action

Robbins LLP is Investigating Allegations that Driven Brands Holdings Inc. (DRVN) Made Material Errors in its Previously Issued Consolidated Financial State
March 09, 2026 12:23 ET | Source: Robbins LLP

BSX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Boston Scientific Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that Boston Scientific Corporation (BSX) Misled Investors Regarding Projected Revenue
March 09, 2026 12:23 ET | Source: Robbins LLP

AQST Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Aquestive Therapeutics, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Aquestive Therapeutics, Inc. (AQST) Misled Investors Regarding Approval of Anaphylm
March 05, 2026 15:17 ET | Source: Robbins LLP

Robbins LLP Urges INO Stockholders Who Lost Money Investing in Inovio Pharmaceuticals, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
March 05, 2026 15:12 ET | Source: Robbins LLP

Robbins LLP Urges Former DOOR Stockholders Who Lost Money Investing in Masonite International Corporation to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Masonite International Corporation (DOOR) Misled Investors Regarding its Acquisition by Owens Corning's Doors
March 05, 2026 14:55 ET | Source: Robbins LLP

Robbins LLP Urges KD Stockholders Who Lost Money Investing in Kyndryl Holdings, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements